{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:46:33Z","timestamp":1782535593385,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chang Gung Memorial Hospital Research Grants","award":["CMRPG3P0191 and CMRPG3P0051~2"],"award-info":[{"award-number":["CMRPG3P0191 and CMRPG3P0051~2"]}]},{"name":"National Science and Technology Council Grants","award":["NSTC 113-2314-B-182A-040"],"award-info":[{"award-number":["NSTC 113-2314-B-182A-040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"DOI":"10.1007\/s00417-026-07341-x","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:16:43Z","timestamp":1782533803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Visual and refractive outcomes of retinopathy of prematurity in school-age patients"],"prefix":"10.1007","author":[{"given":"Yi-Hsuan","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Liang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene Yu-Chuan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Shiou","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"7341_CR1","doi-asserted-by":"publisher","first-page":"e2021053924","DOI":"10.1542\/peds.2021-053924","volume":"150","author":"K Sabri","year":"2022","unstructured":"Sabri K, Ells AL, Lee EY et al (2022) Retinopathy of Prematurity: A Global Perspective and Recent Developments. Pediatrics 150:e2021053924. https:\/\/doi.org\/10.1542\/peds.2021-053924","journal-title":"Pediatrics"},{"key":"7341_CR2","doi-asserted-by":"publisher","first-page":"101018","DOI":"10.1016\/j.preteyeres.2021.101018","volume":"88","author":"AS Tsai","year":"2022","unstructured":"Tsai AS, Chou HD, Ling XC et al (2022) Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF). Prog Retin Eye Res 88:101018. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.101018","journal-title":"Prog Retin Eye Res"},{"key":"7341_CR3","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1038\/s41598-023-31234-2","volume":"13","author":"SH Park","year":"2023","unstructured":"Park SH, Ma DJ, Choi DG (2023) Long-term visual outcomes in children with regressed retinopathy of prematurity. Sci Rep 13:4066. https:\/\/doi.org\/10.1038\/s41598-023-31234-2","journal-title":"Sci Rep"},{"key":"7341_CR4","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1167\/iovs.13-11765","volume":"54","author":"J Wang","year":"2013","unstructured":"Wang J, Ren X, Shen L et al (2013) Development of refractive error in individual children with regressed retinopathy of prematurity. Invest Ophthalmol Vis Sci 54:6018\u20136024. https:\/\/doi.org\/10.1167\/iovs.13-11765","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7341_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1001\/jamaophthalmol.2013.5812","volume":"132","author":"GE Holmstr\u00f6m","year":"2014","unstructured":"Holmstr\u00f6m GE, K\u00e4llen K, Hellstr\u00f6m A et al (2014) Ophthalmologic Outcome at 30 Months\u2019 Corrected Age of a Prospective Swedish Cohort of Children Born Before 27 Weeks of Gestation: The Extremely Preterm Infants in Sweden Study. JAMA Ophthalmol 132:182\u2013189. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.5812","journal-title":"JAMA Ophthalmol"},{"key":"7341_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3109\/09273972.2014.904899","volume":"22","author":"H Gursoy","year":"2014","unstructured":"Gursoy H, Basmak H, Bilgin B et al (2014) The effects of mild-to-severe retinopathy of prematurity on the development of refractive errors and strabismus. Strabismus 22:68\u201373. https:\/\/doi.org\/10.3109\/09273972.2014.904899","journal-title":"Strabismus"},{"key":"7341_CR7","doi-asserted-by":"publisher","first-page":"384","DOI":"10.18502\/jovr.v17i3.11576","volume":"17","author":"M Farvardin","year":"2022","unstructured":"Farvardin M, Kalantari Z, Talebnejad M et al (2022) Long-term Visual and Refractive Outcomes of Argon Laser-treated Retinopathy of Prematurity. J Ophthalmic Vis Res 17:384\u2013389. https:\/\/doi.org\/10.18502\/jovr.v17i3.11576","journal-title":"J Ophthalmic Vis Res"},{"key":"7341_CR8","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/opx.0000000000000533","volume":"92","author":"L Ruan","year":"2015","unstructured":"Ruan L, Shan HD, Liu XZ et al (2015) Refractive status of Chinese with laser-treated retinopathy of prematurity. Optom Vis Sci 92:S3\u20139. https:\/\/doi.org\/10.1097\/opx.0000000000000533","journal-title":"Optom Vis Sci"},{"key":"7341_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ (2011) Efficacy of Intravitreal Bevacizumab for Stage 3\u2009+\u2009Retinopathy of Prematurity. N Engl J Med 364:603\u2013615. https:\/\/doi.org\/10.1056\/NEJMoa1007374","journal-title":"N Engl J Med"},{"key":"7341_CR10","doi-asserted-by":"publisher","unstructured":"Abri Aghdam K, Khadamy J, Falavarjani KG et al (2016) Refractive outcomes following the treatment of retinopathy of prematurity in the anti-VEGF era: a literature review. J AAPOS 20:539\u2009\u2013\u200940.e3. https:\/\/doi.org\/10.1016\/j.jaapos.2016.09.013","DOI":"10.1016\/j.jaapos.2016.09.013"},{"key":"7341_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/cxo.13019","volume":"103","author":"Q Meng","year":"2020","unstructured":"Meng Q, Cheng Y, Wu X et al (2020) Refractive error outcomes after intravitreal ranibizumab for retinopathy of prematurity. Clin Exp Optom 103:495\u2013500. https:\/\/doi.org\/10.1111\/cxo.13019","journal-title":"Clin Exp Optom"},{"key":"7341_CR12","doi-asserted-by":"publisher","first-page":"e39251","DOI":"10.1097\/md.0000000000039251","volume":"103","author":"HF Tung","year":"2024","unstructured":"Tung HF, Chen YL, Chen YC et al (2024) Six years follow-up of type 1 retinopathy of prematurity (ROP) treated with intravitreal injection of ranibizumab and bevacizumab: Long-Term Outcomes of intravitreal injection in Type 1 ROP. Med (Baltim) 103:e39251. https:\/\/doi.org\/10.1097\/md.0000000000039251","journal-title":"Med (Baltim)"},{"key":"7341_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ajo.2018.05.002","volume":"192","author":"Y-S Lee","year":"2018","unstructured":"Lee Y-S, See L-C, Chang S-H et al (2018) Macular Structures, Optical Components, and Visual Acuity in Preschool Children after Intravitreal Bevacizumab or Laser Treatment. Am J Ophthalmol 192:20\u201330. https:\/\/doi.org\/10.1016\/j.ajo.2018.05.002","journal-title":"Am J Ophthalmol"},{"key":"7341_CR14","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/bjophthalmol-2019-314610","volume":"104","author":"Y-C Chen","year":"2020","unstructured":"Chen Y-C, Chen S-N (2020) Foveal microvasculature, refractive errors, optical biometry and their correlations in school-aged children with retinopathy of prematurity after intravitreal antivascular endothelial growth factors or laser photocoagulation. Br J Ophthalmol 104:691\u2013696. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-314610","journal-title":"Br J Ophthalmol"},{"key":"7341_CR15","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","volume":"128","author":"MF Chiang","year":"2021","unstructured":"Chiang MF, Quinn GE, Fielder AR et al (2021) International Classification of Retinopathy of Prematurity, Third Edition. Ophthalmology 128:e51\u2013e68. https:\/\/doi.org\/10.1016\/j.ophtha.2021.05.031","journal-title":"Ophthalmology"},{"key":"7341_CR16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/opo.12814","volume":"41","author":"FG Rauscher","year":"2021","unstructured":"Rauscher FG, Francke M, Hiemisch A et al (2021) Ocular biometry in children and adolescents from 4 to 17 years: a cross-sectional study in central Germany. Ophthalmic Physiol Opt 41:496\u2013511. https:\/\/doi.org\/10.1111\/opo.12814","journal-title":"Ophthalmic Physiol Opt"},{"key":"7341_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/bjophthalmol-2021-319431","volume":"107","author":"X He","year":"2023","unstructured":"He X, Sankaridurg P, Naduvilath T et al (2023) Normative data and percentile curves for axial length and axial length\/corneal curvature in Chinese children and adolescents aged 4\u201318 years. Br J Ophthalmol 107:167\u2013175. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-319431","journal-title":"Br J Ophthalmol"},{"key":"7341_CR18","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.1111\/aos.17515","volume":"103","author":"A Fie\u00df","year":"2025","unstructured":"Fie\u00df A, Gi\u00dfler S, Hartmann A et al (2025) Visual acuity, amblyopia and refractive error in preterm children with and without retinopathy of prematurity - Results from the Gutenberg Prematurity Study Young (GPSY). Acta Ophthalmol 103:e472\u2013e84. https:\/\/doi.org\/10.1111\/aos.17515","journal-title":"Acta Ophthalmol"},{"key":"7341_CR19","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1167\/iovs.10-5234","volume":"51","author":"T-C Chen","year":"2010","unstructured":"Chen T-C, Tsai T-H, Shih Y-F et al (2010) Long-term Evaluation of Refractive Status and Optical Components in Eyes of Children Born Prematurely. Invest Ophthalmol Vis Sci 51:6140\u20136148. https:\/\/doi.org\/10.1167\/iovs.10-5234","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7341_CR20","doi-asserted-by":"publisher","unstructured":"McLoone EM, O\u2019Keefe M, McLoone SF et al (2006) Long-term refractive and biometric outcomes following diode laser therapy for retinopathy of prematurity. J Am Association Pediatr Ophthalmol Strabismus 10:454\u2009\u2013\u200959. https:\/\/doi.org\/10.1016\/j.jaapos.2006.05.005","DOI":"10.1016\/j.jaapos.2006.05.005"},{"key":"7341_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.21037\/tp.2020.03.01","volume":"9","author":"Y Wang","year":"2020","unstructured":"Wang Y, Pi L-H, Zhao R-L et al (2020) Refractive status and optical components of premature babies with or without retinopathy of prematurity at 7 years old. Translational Pediatr 9:108\u2013116","journal-title":"Translational Pediatr"},{"key":"7341_CR22","doi-asserted-by":"publisher","first-page":"e1439","DOI":"10.1111\/aos.15116","volume":"100","author":"A Fiess","year":"2022","unstructured":"Fiess A, Fauer A, Mildenberger E et al (2022) Refractive error, accommodation and lens opacification in adults born preterm and full-term: Results from the Gutenberg Prematurity Eye Study (GPES). Acta Ophthalmol 100:e1439\u2013e50. https:\/\/doi.org\/10.1111\/aos.15116","journal-title":"Acta Ophthalmol"},{"key":"7341_CR23","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","volume":"132","author":"MM Geloneck","year":"2014","unstructured":"Geloneck MM, Chuang AZ, Clark WL et al (2014) Refractive Outcomes Following Bevacizumab Monotherapy Compared With Conventional Laser Treatment: A Randomized Clinical Trial. JAMA Ophthalmol 132:1327\u20131333. https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.2772","journal-title":"JAMA Ophthalmol"},{"key":"7341_CR24","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1007\/s00417-022-05663-0","volume":"260","author":"X Lu","year":"2022","unstructured":"Lu X, Zeng X, Chen M et al (2022) Refractive and biometrical characteristics of children with retinopathy of prematurity who received laser photocoagulation or intravitreal ranibizumab injection. Graefes Arch Clin Exp Ophthalmol 260:3213\u20133219. https:\/\/doi.org\/10.1007\/s00417-022-05663-0","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7341_CR25","doi-asserted-by":"publisher","first-page":"e0225643","DOI":"10.1371\/journal.pone.0225643","volume":"14","author":"QQ Tan","year":"2019","unstructured":"Tan QQ, Christiansen SP, Wang J (2019) Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents: A meta-analysis and systematic review. PLoS ONE 14:e0225643. https:\/\/doi.org\/10.1371\/journal.pone.0225643","journal-title":"PLoS ONE"},{"key":"7341_CR26","doi-asserted-by":"publisher","first-page":"e042384","DOI":"10.1136\/bmjopen-2020-042384","volume":"11","author":"Q Kong","year":"2021","unstructured":"Kong Q, Ming WK, Mi XS (2021) Refractive outcomes after intravitreal injection of antivascular endothelial growth factor versus laser photocoagulation for retinopathy of prematurity: a meta-analysis. BMJ Open 11:e042384. https:\/\/doi.org\/10.1136\/bmjopen-2020-042384","journal-title":"BMJ Open"},{"key":"7341_CR27","doi-asserted-by":"publisher","unstructured":"Smith EL 3rd, Kee CS, Ramamirtham R et al (2005) Peripheral vision can influence eye growth and refractive development in infant monkeys. Invest Ophthalmol Vis Sci 46:3965\u20133972. https:\/\/doi.org\/10.1167\/iovs.05-0445","DOI":"10.1167\/iovs.05-0445"},{"key":"7341_CR28","doi-asserted-by":"publisher","unstructured":"Yalin Imamoglu E, Gunay M, Gursoy T et al (2014) Effect of laser photocoagulation on plasma levels of VEGF-A, VEGFR-2, and Tie2 in infants with retinopathy of prematurity. J Am Association Pediatr Ophthalmol Strabismus 18:466\u2009\u2013\u200970. https:\/\/doi.org\/10.1016\/j.jaapos.2014.07.159","DOI":"10.1016\/j.jaapos.2014.07.159"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07341-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07341-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07341-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:16:44Z","timestamp":1782533804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07341-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":28,"alternative-id":["7341"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07341-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"11 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}